AI Proteins is a protein therapy developer capable of developing inexpensive, durable, highly specific proteins. AI Proteins is reimagining protein therapy with a fresh approach to designing entirely new proteins. Using AI-based design and a high-throughput drug discovery platform, AI Proteins creates de novo proteins optimized for specific therapeutic applications. AI Proteins announced the completion of an $18.2 million seed round, co-led by Cobro Ventures and Lightchain Capital.
This article is reproduced from: https://www.itjuzi.com/investevent/13647836
This site is for inclusion only, and the copyright belongs to the original author.